The EU Court of First Instance annuls the Commission’s decision against a pharmaceutical company as it failed to prove the existence of an agreement (Bayer)
Case T-41/96 R
Bayer AG v Commission of the European Communities*
Where the Commission prohibits a manufacturer of pharmaceutical products from refusing to supply a medicinal product in order to prevent an increase in parallel exports from Member States where the product is marketed
Access to this article is restricted to subscribers
Already Subscribed? Sign-in